Abbvie Inc
NYSE: ABBV
$193.47
-$0.15 (-0.1%)
Closing Price on September 20, 2024
ABBV Articles
U.S. equity markets opened flat this morning, largely due to a slew of data from Europe that essentially cancelled any good news with an equal dollop of bad. U.S. unemployment data came out before...
Published:
Last Updated:
ThinkstockHave some widely owned health care names hit a wall when it comes to growth and earnings? In a research report issued today, Credit Suisse Group Inc. (NYSE: CS) issues some not very...
Published:
Last Updated:
Jon OggThese are some of this Thursday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. AbbVie Inc. (NYSE: ABBV) started as Neutral at Credit Suisse. Akamai...
Published:
Stocks have rallied sharply during January after the last-minute congressional compromise on the fiscal cliff. While the deal was far from perfect, it averted not only a disaster for the U.S....
Published:
Last Updated:
ThinkstockAfter a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF) predict that 2013 could show more of the same. However they...
Published:
Last Updated:
courtesy of NetflixChina’s services index rises to 56.1 in December, a sign of healthy expansion. (Reuters) Apple Inc. (NASDAQ: AAPL) tests a new iPhone and iOS 7. (Reuters) A court rejects an...
Published: